2765676-81-9
Chemical Structure
CDK7-IN-18
- CAS No.: 2765676-81-9
- Formula:C22H24F3N7OS
- Molecular Weight:491.53
IUPAC Name: N-((3-(2-(((S)-6,6-dimethylpiperidin-3-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)-1H-indol-7-yl)(methyl)(oxo)-l6-sulfanylidene)cyanamide
InChIKey: KTVYKZXYJQGXFT-JKFVLOHPSA-N
SMILES: CC1(CC[C@@H](CN1)NC2=NC=C(C(C3=CNC4=C(C=CC=C34)S(C)(=O)=NC#N)=N2)C(F)(F)F)C
Biological Activity: CDK7-IN-18 is a potent inhibitor of CDK7. CDK7-IN-18 is a pyrimidinyl derivative compound. CDK7-IN-18 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 15)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK7-IN-18 | CDK7-IN-18 is a potent inhibitor of CDK7. CDK7-IN-18 is a pyrimidinyl derivative compound. CDK7-IN-18 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 15). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
